BioMarin to Participate in Three Upcoming Virtual Investor Conferences - Nov 12, 2020

  • Barclays Gene Editing & Gene Therapy Summit on November 16 at 1:00pm ET
  • Stifel 2020 Virtual Healthcare Conference on November 17 at 2:00pm ET
  • Jefferies Virtual London Healthcare Conference on November 17 at 1:10pm ET/6:10pm GMT

 

SAN RAFAEL, Calif., Nov. 12, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:

 

Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-upcoming-virtual-investor-conferences-301171792.html

SOURCE BioMarin Pharmaceutical Inc.


Company Codes: NASDAQ-NMS:BMRN

Back to news